Cite
APA Citation
Blauvelt, A., Ferris, L., Yamauchi, P., Qureshi, A., Leonardi, C., Farahi, K., Fakharzadeh, S., Hsu, M., Li, S., Chevrier, M., Smith, K., Goyal, K., Chen, Y., Muñoz‐Elías, E., & Callis Duffin, K. (2017). extension of ustekinumab maintenance dosing interval in moderate‐to‐severe psoriasis: results of a phase IIIb, randomized, double‐blinded, active‐controlled, multicentre study (PSTELLAR). British journal of dermatology, 177, 1552–1561. http://access.bl.uk/ark:/81055/vdc_100172527922.0x00001d